Why the study?
Dysregulation of miRNA-126, -145, and -155 is linked to atherosclerotic lesion formation, but their association with unfavourable atherosclerotic plaque characteristics needed evaluation.
Comparison
Levels of circulating miRNA-126, miRNA-145, and miRNA-155
Design
Prospective study
Authors
Loading...
miRNA-plaque associations in stable CAD warrant prospective validation; leaves open biomarker utility for risk stratification.
Circulating miRNA-126 and miRNA-145 are associated with increased plaque necrolipidic tissue content and may serve as potential biomarkers for plaque vulnerability.
Knoka et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: